CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
3,458.00 1,807.00 6,581.00 8,056.00 10,854.00 12,525.00 15,723.00 11,455.00 10,993.00 10,598.00
Receivables
12,164.00 13,181.00 17,631.00 19,617.00 21,742.00 24,431.00 27,276.00 35,227.00 36,469.00 39,779.00
Inventory
14,760.00 15,296.00 16,450.00 17,516.00 18,496.00 17,760.00 19,090.00 18,025.00 18,107.00 19,246.00
Other current assets
660.00 945.00 4,581.00 5,113.00 5,277.00 5,292.00 3,544.00 3,151.00 3,076.00 5,091.00
Total current assets
31,042.00 31,229.00 45,243.00 50,302.00 56,369.00 60,008.00 65,633.00 67,858.00 68,645.00 74,714.00
Property, Plant, Equpment (Net)
10,175.00 10,292.00 11,349.00 12,044.00 12,606.00 12,896.00 12,873.00 13,183.00 12,993.00 13,083.00
Long-Term Investments
— 112.00 15,732.00 17,314.00 20,812.00 23,025.00 21,096.00 23,019.00 28,934.00 32,669.00
Goodwill and Intangible Assets (Total)
51,760.00 52,081.00 115,202.00 112,870.00 110,694.00 108,147.00 102,953.00 120,506.00 118,595.00 110,986.00
Long-term assets (Other)
1,485.00 1,417.00 8,930.00 9,059.00 9,505.00 9,801.00 7,848.00 7,910.00 8,104.00 7,113.00
Total non-current assets
63,420.00 63,902.00 151,213.00 172,147.00 174,346.00 172,991.00 162,642.00 181,870.00 184,570.00 178,824.00
Total Assets
94,462.00 95,131.00 196,456.00 222,449.00 230,715.00 232,999.00 228,275.00 249,728.00 253,215.00 253,538.00
Accounts Payable
7,946.00 8,863.00 8,925.00 10,492.00 11,138.00 12,544.00 14,838.00 14,897.00 15,892.00 17,641.00
Accrued Expenses
6,937.00 6,581.00 10,711.00 12,133.00 14,243.00 17,670.00 18,745.00 23,515.00 20,810.00 22,387.00
Current Part of Debt
1,916.00 4,821.00 1,985.00 3,781.00 5,440.00 4,205.00 1,778.00 2,972.00 5,743.00 4,068.00
Other current liabilities
6,937.00 23.00 4,876.00 4,821.00 5,827.00 5,604.00 2,817.00 1,141.00 1,183.00 1,116.00
Total current liabilities
26,250.00 30,648.00 44,009.00 53,303.00 62,017.00 67,807.00 69,421.00 79,189.00 84,609.00 88,692.00
Long Term Debt (Total)
25,615.00 22,181.00 71,444.00 64,699.00 59,207.00 51,971.00 50,476.00 58,638.00 60,527.00 60,502.00
Long Term Tax Liability (Deferred)
4,214.00 2,996.00 7,677.00 7,294.00 6,794.00 6,270.00 4,016.00 4,311.00 3,806.00 3,832.00
Non-current Liabilities (Other)
1,549.00 1,611.00 14,783.00 14,057.00 14,239.00 13,393.00 15,793.00 14,920.00 13,644.00 11,487.00
Total non-current liabilities
31,378.00 26,788.00 93,904.00 104,976.00 98,997.00 89,811.00 87,085.00 93,903.00 92,876.00 89,464.00
Total liabilities
57,628.00 57,436.00 137,913.00 158,279.00 161,014.00 157,618.00 156,506.00 173,092.00 177,485.00 178,156.00
Additional Paid In Capital
31,618.00 — — — — — — — — —
Common Stock (Net)
17.00 32,096.00 45,440.00 45,972.00 46,513.00 47,377.00 48,193.00 48,992.00 49,661.00 50,402.00
Retained Earnings
38,983.00 43,556.00 40,911.00 45,108.00 49,640.00 54,906.00 56,398.00 61,604.00 62,837.00 61,196.00
Treasury Stock
33,452.00 37,796.00 28,228.00 28,235.00 28,178.00 28,173.00 31,858.00 33,838.00 36,818.00 36,790.00
Shareholders Equity (Other)
(31.00) — — — — — — — — —
Common Equity (Total)
36,834.00 37,695.00 58,543.00 64,170.00 69,701.00 75,381.00 71,769.00 76,636.00 75,730.00 75,382.00
Shareholders Equity (Total)
36,834.00 37,695.00 58,543.00 64,170.00 69,701.00 75,381.00 71,769.00 76,636.00 75,730.00 75,382.00
Shareholders Equity and Liabilities (Total)
94,462.00 95,131.00 196,456.00 222,449.00 230,715.00 232,999.00 228,275.00 249,728.00 253,215.00 253,538.00
Shares (Common)
1,061.00 1,014.00 1,295.00 1,302.00 1,310.00 1,322.00 1,300.00 1,288.00 1,260.00 1,271.00
Shareholders Equity (Tangible)
(14,926.00) (14,386.00) (56,659.00) (48,700.00) (40,993.00) (32,766.00) (31,184.00) (43,870.00) (42,865.00) (35,604.00)
Net Debt
24,073.00 25,195.00 66,848.00 60,424.00 53,793.00 43,651.00 36,531.00 50,155.00 55,277.00 53,972.00
Total Debt
27,531.00 27,002.00 73,429.00 68,480.00 64,647.00 56,176.00 52,254.00 61,610.00 66,270.00 64,570.00

Fold the line items

In millions of $ except per-share values · columns are period end dates